Mercer Global Advisors
LKFT

Mercer Global Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Mercer Global Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,602
Closed -$511K – 1366
2020
Q3 		$511K Buy
3,602
+424
+13% +$70.7K 0.01% 776
2020
Q2 		$627K Buy
+3,178
New +$658K 0.01% 605

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mercer Global Advisors's LKFT Position: Q4 2020 in Review

Mercer Global Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 3,602 shares — an estimated $511K sold.

Mercer Global Advisors first reported a position in LKFT in Q2 2020 and held it in 2 quarters. The position peaked at $627K in Q2 2020. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Mercer Global Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 3,602 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $511K.
  • Mercer Global Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2020 and held it in 2 quarters.
  • Mercer Global Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $627K in Q2 2020.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Mercer Global Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.